3,4-Ethylidenedioxyamphetamine

From WikiMD.com Medical Encyclopedia

3,4-Ethylidenedioxyamphetamine (EDA) is a synthetic compound belonging to the amphetamine class of psychoactive drugs. It is structurally related to other substituted amphetamines, such as 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA), which are known for their stimulant and empathogenic effects.

Chemical Structure and Properties[edit | edit source]

3,4-Ethylidenedioxyamphetamine is characterized by the presence of an ethylidene group attached to the 3,4-methylenedioxy ring of the amphetamine backbone. This modification distinguishes it from other related compounds and influences its pharmacological properties. The chemical formula for EDA is C12H15NO2.

Pharmacology[edit | edit source]

As a member of the substituted amphetamines, EDA is believed to act primarily as a serotonin and dopamine releasing agent. This mechanism of action is similar to that of other psychoactive amphetamines, which increase the levels of these neurotransmitters in the brain, leading to enhanced mood, increased energy, and altered perception.

Effects[edit | edit source]

The effects of 3,4-ethylidenedioxyamphetamine are not well-documented in scientific literature, but it is presumed to have stimulant and empathogenic properties similar to those of MDA and MDMA. Users may experience increased sociability, euphoria, and heightened sensory perception.

Legal Status[edit | edit source]

The legal status of EDA varies by country. In many jurisdictions, it is classified as a controlled substance due to its structural similarity to other regulated amphetamines. This classification restricts its manufacture, distribution, and possession.

Synthesis[edit | edit source]

The synthesis of 3,4-ethylidenedioxyamphetamine involves the chemical modification of the methylenedioxy ring structure. This process requires advanced knowledge of organic chemistry and access to specific reagents and equipment.

Safety and Toxicity[edit | edit source]

Due to the lack of comprehensive studies, the safety profile and toxicity of EDA are not well understood. As with other psychoactive substances, there is a potential for adverse effects, including neurotoxicity, cardiovascular issues, and psychological dependence.

Related Compounds[edit | edit source]

See Also[edit | edit source]

Related pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD